期刊文献+

纳米立方液晶系统作为抗肿瘤药物载体的研究进展 被引量:1

Research Progress of Nano Cubic Liquid Crystal Systems as Antitumor Drug Carriers
下载PDF
导出
摘要 对近年来纳米立方液晶系统作为药物载体在抗肿瘤方面的研究进展进行综述。介绍纳米液晶的结构、特点、制备方法和常用材料,及其在肿瘤方面的应用。纳米立方晶具有提高药物溶解度和稳定性的优势,并具有良好的生物相容性,作为新型纳米药物载体广泛受到人们关注。 The research progress in nano cubic crystal systems as drug carriers for antitumor agents in recent years was summa- rized. The structure, characteristics, preparation methods, common used materials and application of nano liquid crystals containing antitumor drugs were introduced. Nano cubic crystals showed the advantages of improving the solubility and stability of drugs and good biocompatibility that made them achieve widely attention as a new type of nano drug carriers.
作者 初明慧 纪宏宇 王海荣 冯佳玉 张诚诚 吴琳华 Chu Minghui;Ji Hongyu;Wang Hairong;Feng Jiayu;Zhang Chengcheng;Wu Linhua(Department of Phar- macy, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China;College of Pharmacy, Harbin Medical University;Key Laboratory of Pharmacetieal Research, College of Heilongjiang Province)
出处 《中国药师》 CAS 2018年第4期710-714,共5页 China Pharmacist
关键词 纳米立方液晶 抗肿瘤 新型药物载体 研究进展 Nano cubic liquid crystals Anti-tumor New drug carriers Research progress
  • 相关文献

参考文献5

二级参考文献66

  • 1甘莉,甘勇,沈锦秋,朱家壁.地塞米松纳米立方液晶眼用制剂家兔房水药代动力学[J].中国药科大学学报,2009,40(4):327-331. 被引量:11
  • 2Wan-Yee Lau,Eric C.H.Lai,Stephanie H.Y.Lau.The current role of neoadjuvant/adjuvant/chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma:a systematic review[J].Hepatobiliary & Pancreatic Diseases International,2009,8(2):124-133. 被引量:24
  • 3王志宁,郑利强,李干佐.蔗糖对MO/水立方液晶体系流变性质的影响[J].化学学报,2005,63(4):274-278. 被引量:15
  • 4王志宁,郑利强.类脂立方液晶作为药物载体的研究[J].化学进展,2005,17(3):417-422. 被引量:16
  • 5Muller F, Salonen A, Glatter O. Monoglyceride-based cubosomes stabilized by Laponite:Separating the effects of stabilizer, pH and temperature [J]. Colloids Surf A Physicochem Eng Asp ,2010,358( 1/3 ) :50-56.
  • 6Sallam A S, Khalil E, Ibrahim H, et al. Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate [ J ]. Eur J Pharm Biopharm,2002,53 ( 3 ) :343-352.
  • 7Amar-Yuli I, Wachtel E, Shalev D E,et al. Low viscosity reversed hexagonal mesophases induced by hydrophilic additives [ J ]. J Phys Chem B, 2008, 112 (13):3971-3982.
  • 8Libster D, Aserin A, Garti N. Interactions of biomacromo-lecules with reverse hexagonal liquid crystals : drug delivery and crystallization applications [ J ]. J Colloid Interface Sci,2011,356( 2 ) :375-386.
  • 9Shah M H, Paradkar A. Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matrices [ J ]. Eur J Pharm Biopharm, 2007,67 ( 1 ) : 166-174.
  • 10Mulet X,Kennedy D F, Conn C E,et al. High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles [ J ]. lnt J Pharm ,2010,395 ( 1/2 ) :290-297.

共引文献32

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部